Once you have a better idea of your triggers, make a plan to address or avoid them
Wegovy (semaglutide) is a medicine prescribed for chronic weight management
For patients with type 2 diabetes, regular physical activity improves insulin sensitivity, supports cardiovascular health, and helps preserve muscle mass during weight loss
However, reduced side effects at lower doses make it likely there are also reduced therapeutic effects
GI side effects (nausea, vomiting, constipation) correlate with the plasma peak, not with average exposure
72% male) from 804 sites in 41 countries with overweight or obesity (BMI of 27 kg/m or higher) who were enrolled and treated with weekly injections of semaglutide (at doses slowly titrated to 2.4 mg at week 16) or placebo